NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.21% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 5.02% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 5.00% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.94% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.88% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.85% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.75% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.67% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.56% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.55% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.28% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 3.25% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.21% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.16% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| VCEL | Vericel Corp Ord | Healthcare | Biotechnology | 3.02% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.01% |